Fig. 14From: Emerging strategies to overcome resistance to third-generation EGFR inhibitorsChemical structures of natural products with their synthetic analogs and other inhibitors (no specific IC50 values are shown due to variations in EGFR-mutant cell line survival and apoptosis assays)Back to article page